drugset
drugset / Trial / NCT07349329

A Study to Evaluate the Efficacy and Safty of 608 in Patients With Non- Radiographic Axial Spondyloarthritis (Nr-axSpA)

NCT07349329 ↗

Phase 3 Not yet recruiting 380 enrolled Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study will evaluate the efficacy and safety of 608 in patients with nr-axSpA.

Timeline

Start
2026-03-09
Primary completion
2028-04-19
Completion
2029-02-21

Drugs

EvaluationDrugModalityDoseRoute
Subject 608 Unknown — Subcutaneous

Indications

spondyloarthropathy